Secondary amine-initiated three-component synthesis of 3,4-dihydropyrimidinones and thiones involving alkynes, aldehydes and thiourea/urea

• Jie-Ping Wan,
• Yunfang Lin,
• Kaikai Hu and
• Yunyun Liu

Beilstein J. Org. Chem. 2014, 10, 287–292, doi:10.3762/bjoc.10.25

• activities have been discovered in many synthesized small DHPMs. For example, monastrol (A) [5], (R)-SQ 32926 (B) [6] and (+)-SNAP-7941(C) [7] are lead compounds possessing outstanding antitumor, antihypertensive and melanin-concentrating hormone receptor antagonism activities, respectively (Figure 1). More

A chemist and biologist talk to each other about caged neurotransmitters

• Graham C.R. Ellis-Davies

Beilstein J. Org. Chem. 2013, 9, 64–73, doi:10.3762/bjoc.9.8

• between the two communities to further the creative development and application of these powerful optical probes. Keywords: caged compounds; cell signaling; electrophysiology; neuronal currents; photolabile neurotransmitters; rates of reaction; receptor antagonism; Introduction The first biologically

Synthesis of 2-substituted 9-oxa-guanines {5-aminooxazolo[5,4-d]pyrimidin- 7(6H)-ones} and 9-oxa-2-thio- xanthines {5-mercaptooxazolo[5,4-d]pyrimidin- 7(6H)-ones}

• Subrata Mandal,
• Wen Tai Li,
• Yan Bai,
• Jon D. Robertus and
• Sean M. Kerwin

Beilstein J. Org. Chem. 2008, 4, No. 26, doi:10.3762/bjoc.4.26

• prepared were found to inhibit ricin with IC50 ca. 1–3 mM. Keywords: Annulation; Click Chemistry; Cyclization; Purine Analogs; Ricin; Introduction Oxazolo[5,4-d]pyrimidines have been reported to possess a variety of biological activities including kinase inhibition [1][2], adenosine receptor antagonism